Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research

Pharmacoepidemiology and Drug Safety

Volumn 16, Issue 4, 2007, Pages 393-401

  Lewis, James D ^a   Schninnar, Rita ^a   Bilker, Warren B ^a   Wang, Xingmei ^a   Strom, Brian L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Case control studies; Database validation; Medical records database

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; PROTON PUMP INHIBITOR; SUCRALFATE; WARFARIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCULATION; CANCER RISK; CASE CONTROL STUDY; CIGARETTE SMOKING; COLON CANCER; DATA BASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG EXPOSURE; DRUG USE; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFORMATION PROCESSING; LOGISTIC REGRESSION ANALYSIS; MEDICAL RECORD; MEDICAL RESEARCH; OBESITY; OUTCOMES RESEARCH; PEPTIC ULCER; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK REDUCTION; STROKE; VALIDATION STUDY;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; COLONIC NEOPLASMS; DATABASES; DIABETES COMPLICATIONS; FAMILY PRACTICE; GREAT BRITAIN; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LOGISTIC MODELS; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MYOCARDIAL INFARCTION; OBESITY; ODDS RATIO; PEPTIC ULCER; PHARMACOEPIDEMIOLOGY; POTASSIUM COMPOUNDS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 34247487800     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1335     Document Type: Article

References (11)

1. Jick SS, Kaye JA, Vasilakis-Scaramozza C, et al. Validity of the general practice research database. Pharmacotherapy 2003; 23: 686-689.
2. Lewis JD, Brensinger C, Bilker WB, Strom BL. Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease. Pharmacoepidemiol Drug Saf 2002; 11: 211-218.
3. Soriano JB, Maier WC, Visick G, Pride NB. Validation of general practitioner-diagnosed COPD in the UK General Practice Research Database. Eur J Epidemiol 2001; 17: 1075-1080.
4. Lawrenson R, Todd JC, Leydon GM, Williams TJ, Farmer RD. Validation of the diagnosis of venous thromboembolism in general practice database studies. Br J Clin Pharmacol 2000; 49: 591-596.
5. Hansell A, Hollowell J, Nichols T, McNiece R, Strachan D. Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4). Thorax 1999; 54: 413-419.
6. Garcia Rodriguez LA, Perez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 1998; 45: 419-425.
7. Lewis JD, Bilker WB, Weinstein RB, Strom BL. The relationship between time since registration and measured incidence rates in the General Practice Research Database. Pharmacoepidemiol Drug Saf 2005; 14: 443-451.
8. De Wilde S, Carey IM, Bremner SA, et al. A comparison of the recording of 30 common childhood conditions in the Doctor's Independent Network and General Practice Research Databases. Health Stat Q 2004; Summer, (22): 21-31.
9. Hollowell J. The General Practice Research Database: quality of morbidity data. Popul Trends. 1997; Spring; (87): 36-40.
10. Rothman K, Greenland S. Case-control studies. In Modern Epidemiology (2nd ed.), Rothman Y, Greenland S (eds). Lippincott-Raven Publishers: Philadelphia, 1998; 93-114.
11. Hosmer DW Jr, Lemeshow S. 2000. Applied Logistic Regression. (2nd ed.). Wiley: New York.